Facilities

Chinese firm plans ‘first-in-class’ biologics after $325m manufacturing investment

12-Dec-2018 By Ben Hargreaves

The second phase of Changzhou Qianhong Bio-pharma manufacturing project sees a further ¥1 billion devoted to increasing tablet and injection production.

Biotage acquires Phynexus in $21.5m deal

11-Dec-2018 By Maggie Lynch

Biotage will add PhyNexus’ platform for higher throughput purification at lab-scale.

Lonza and GE look to China with development of biologics facility

11-Dec-2018 By Maggie Lynch

Lonza will work with GE Healthcare to establish a biologics facility in Gunagzhou, China.

WuXi Biologics: Ireland’s largest single-use facility underway

07-Dec-2018 By Flora Southey

The CDMO has broken ground on its first site outside of China – a €325m single-use manufacturing facility in County Louth, Ireland.

Bayer to shed €600m factor VIII facility and 12,000 staff

30-Nov-2018 By Ben Hargreaves

Bayer looks to boost investor confidence by cutting away its animal health unit, selected consumer health brands and a number of jobs to focus on its life sciences businesses.

GE to open fibre-based chromatography facility in UK

27-Nov-2018 By Flora Southey

The Stevenage facility will produce a fibre-based purification platform for the manufacture of biopharmaceuticals, gene therapies and viral vectors.

Q&A

UK cell and gene therapy ecosystem ‘second to none’

26-Nov-2018 By Ben Hargreaves

The UK has a ‘rich and vibrant’ advanced therapeutic manufacturing sector well placed to attract companies post-Brexit, says Keith Thompson, CEO of CGTC.

UK invests to streamline manufacture of next-gen medicine

23-Nov-2018 By Ben Hargreaves

Funding of £7.3m will be provided across three initiatives, with the long-term aim of providing patients with access to cell and gene therapies at a faster rate.

WuXi Biologics announces new discovery, development and manufacturing site in China

23-Nov-2018 By Flora Southey

The CDMO has broken ground on its 1.6 million-square-foot Biologics Innovation Center in Shanghai.

Rentschler opens GMP fill/finish facility in Austria

21-Nov-2018 By Staff Reporter

Aseptic fill/finish contractor Rentschler Fill Solutions inaugurated the new facility in Austria’s eastern town of Rankweil.

ADC Bio secures funding to further manufacturing plans

16-Nov-2018 By Ben Hargreaves

The company announced an investment of £2.5m to design its downstream formulation and filling operations.

NEWS IN BRIEF

WuXi Biologics breaks ground on $240m manufacturing site near Beijing

09-Nov-2018 By Flora Southey

Construction has started at WuXi Biologics’ eighth drug substance manufacturing facility, which CEO Chris Chen says will enable the CDMO to “develop and manufacture biologics more cost effectively”.

Coherus receives US FDA approval for Neulasta biosimilar, pricing 33% lower

09-Nov-2018 By Ben Hargreaves

The company will launch Udenyca onto the US market on January 3, 2019, to compete with Amgen’s originator product and Mylan’s rival biosimilar.

BIO Europe 2018

#BIOEurope: ‘Deal making is off the charts and the IPO window is open’

08-Nov-2018 By Flora Southey

Denmark played host to its first BIO Europe this week, welcoming 4,500 attendees from across the globe – including growing numbers from China and South Korea.

Astellas invests $256m in cell therapy manufacturing buildout

07-Nov-2018 By Ben Hargreaves

The company will construct two facilities in Japan and relocate its regenerative medicine facility in the US.

Product Innovations

Survey Report: State of the global biomanufacturing and bioprocessing industry 2017

In September 2017, BioPharma-Reporter.com conducted its second annual ‘state of the industry’ survey on its user base of biopharmaceutical industry professionals....

Survey Report: State of the Biopharmaceutical Industry 2016

In May 2016, BioPharma-Reporter conducted its inaugural ‘state of the industry’ survey. The key objective of the poll was to gauge views about the current...